Independent Verification and Validation of Engineered Cell Lines
SAM.GOV Due: May 16, 2025 at 08:00 PM UTC
In-Active Sources Sought Source Url

Summary

The opportunity titled 'Independent Verification and Validation of Engineered Cell Lines' is issued by the Advanced Research Projects Agency for Health (ARPA-H) and focuses on the procurement of independent verification and validation (IV&V) services for engineered cell lines used in the Resilient Extended Automatic Cell Therapies (REACT) program. This program aims to develop wireless implantable medical devices that monitor and treat chronic diseases through engineered cells. Contractors with expertise in cellular engineering, FDA regulatory processes, and biomanufacturing are encouraged to bid, particularly those capable of establishing critical quality attributes and process parameters necessary for FDA approval. The work involves ensuring standardization and reproducibility in the manufacturing of cell lines, which is crucial for the success of the REACT program.
Description
  1. BACKGROUND

The Advanced Research Projects Agency for Health (ARPA-H) Resilient Systems Office seeks to support the procurement of independent verification and validation (IV&V) of the engineered cell lines utilized in the Resilient Extended Automatic Cel

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
541990
Set Aside
None
Place of Performance
Washington , District of Columbia
Point of Contact
Full Name Email Phone Type
Larin Harris [email protected] primary